About WSGR Our Practice Our Clients Industry Specialization Attorneys Publications News & Events Careers Pro Bono Search | Contact Us | 中文网页
Print this page

Antitrust

Business Litigation & Counseling

Consumer Litigation

Consumer Regulatory & Privacy

Corporate Finance

Corporate Law & Governance

Employee Benefits & Compensation

Employment Law

Energy & Clean Technology

Entrepreneurial Services

Export Controls

Fund Services

Global Generics

Global Outsourcing Transactions

Intellectual Property

Intellectual Property Counseling & Patents

Intellectual Property Litigation

Internet & Copyright Litigation

Life Sciences

Litigation

Mergers & Acquisitions

Project Development & Finance

Real Estate & Environmental

Retail, Consumer & Advertising

Securities Litigation

Tax

Technology Transactions

Trade Secrets & Employee Mobility Litigation

Trademarks, Copyrights & Advertising

Venture Capital

Wealth Management

White Collar Crime & Government Investigations

Global Generics

In today's fast-growing, highly regulated worldwide generic pharmaceutical market, companies increasingly need guidance to successfully address a wide variety of complex legal issues. Wilson Sonsini Goodrich & Rosati's interdisciplinary global generics practice, representing a cross section of key practice areas including intellectual property, litigation, antitrust, regulatory, corporate, and mergers and acquisitions, is uniquely positioned to provide this counsel.

The members of the firm's global generics practice—including attorneys with advanced scientific degrees in areas such as pharmacology, molecular biology, and organic chemistry—work closely with our generic pharmaceutical clients' legal and scientific personnel and senior management to understand and meet their specific needs both in the U.S. and abroad, particularly in the burgeoning China and India markets. These include antitrust counseling, intellectual property counseling and strategic patent planning, regulatory counseling (including Hatch-Waxman), patent litigation (including Paragraph IV), complex commercial litigation, handling government investigations and administrative actions, and compliance issues and audits.